However, it has recently been reported that CS chains of serglycin can unexpectedly trigger the NF‐κB activation in non‐small cell lung cancer (NSCLC) cells, thereby promoting their invasiveness 150. This evidence concerns the gene NFKB1 and non-small cell lung carcinoma.